Dr. Shaun Patrick McKenzie, MD

Dr. McKenzie practices at Texas Oncology PA in Austin, Texas.

Dr. McKenzie's NPI, 1114189933, was assigned on July 2, 2008. Dr. McKenzie graduated from Texas Tech University Health Sciences Center School of Medicine in 2001. Dr. McKenzie holds Texas license P6220.

Dr. McKenzie's primary practice is Texas Oncology PA, at 4101 James Casey St, Austin, TX 78745 in Travis County. The practice phone is (972) 997-8000.

Dr. McKenzie's primary practice is Texas Oncology PA in Austin, Texas. Dr. McKenzie is also affiliated with St. David's Medical Center. The medical group on file is Texas Oncology. Dmand AI also links Dr. McKenzie to 2 more hospitals, 2 group practices and clinics, 2 medical groups and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. McKenzie practices, 6 sites in all. Vendor and product names are available with a free account.

Surgical oncology is Dr. McKenzie's primary specialty in the NPI Registry, under taxonomy code 2086X0206X. Dr. McKenzie is board certified in surgery by the American Board of Surgery. Dmand AI has Dr. McKenzie's licenses on file in 3 states: Texas, California and Kentucky.

Dmand AI lists colon removal among the conditions Dr. McKenzie treats.

CMS data shows 508 Medicare services from Dr. McKenzie across 15 procedure codes in 2024, for 169 Medicare patients. Medicare paid $49,780 for them.

CMS counts 169 Medicare patients who saw Dr. McKenzie in 2024. The largest group is 65 to 74, with 90 patients. 75% of them have high blood pressure, and 69% have high cholesterol. 7% are also on Medicaid. Their average risk score is 1.99, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. McKenzie's median patient age at 70, with 46% women.

In 2024, Dr. McKenzie wrote 261 Medicare Part D claims for 100 patients. 81% of them were for generic drugs. CMS names the drug for 162 of them, across 9 drugs with 11 or more claims each, at $61,780 in total drug cost. In 2023, CMS named 98 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. McKenzie for performance year 2024, reported through an alternative payment model (APM). Dr. McKenzie accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. McKenzie as offering telehealth.

Upper gastrointestinal (GI) endoscopy for acid reflux: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 19 papers to Dr. McKenzie, published from 2008 to 2014. The most frequent topics are Colectomy, Colorectal Neoplasms and Liver Neoplasms. Dr. McKenzie has published most often in Curr Surg. Dr. McKenzie's most frequent co-authors are Stephen L. Barnes, MD, Julio E. Garcia-Aguilar, MD and Alessio Pigazzi, MD.

CMS Open Payments shows 80 general payments to Dr. McKenzie from 22 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 73% of the total. Stryker Corporation paid the most, $1,887.

Dmand AI lists 1 award for Dr. McKenzie.

Dr. McKenzie graduated from Texas Tech University Health Sciences Center School of Medicine in 2001. Dr. McKenzie is a member of ACS.

Dr. McKenzie is in network with 20 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.